Skip to main content
S 1176 117th Congress Senate Health Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Health care costs and insurance Health programs administration and funding Manufacturing Prescription drugs

Onshoring Essential Antibiotics Act

Introduced: April 15, 2021 Introduced by: Smith, Tina Democratic · Minnesota See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 15, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 15, 2021
Introduced in Senate
 Plain-English summary Congressional Research Service

Onshoring Essential Antibiotics Act

This bill requires the Department of Health and Human Services (HHS) to provide grants to up to three manufacturers of essential generic antibiotic drugs (or of the active pharmaceutical ingredient or key starting material for such a drug). Under the bill, an essential generic antibiotic drug is one that HHS deems to be medically necessary to have available at all times in adequate amounts.

These grants may be used to (1) construct, expand, or upgrade a manufacturing facility in the United States; and (2) manufacture essential generic antibiotic drugs. HHS shall commission a report with (1) recommendations about which drugs should be prioritized in the grant program, and (2) an analysis of the expected effect of domestic drug manufacturing on drug costs to consumers.

HHS may stockpile essential generic antibiotic drugs manufactured in the United States.

The bill provides in funding for the grant program and for HHS to stockpile generic antibiotic drugs.

What's happening now April 15, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1